









Markets
/
Stocks
/
nasdaq-pntg
/

Pennant Group Inc

PNTG

30.350USD

+0.370+1.23%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

1.05BMarket Cap

39.29P/E TTM



Pennant Group Inc

30.350

+0.370+1.23%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Pennant Group Inc

Currency: USD Updated: 2026-02-06

Key Insights

Pennant Group Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 8 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 35.83.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Pennant Group Inc's Score

Industry at a Glance

Industry Ranking

8 / 75

Overall Ranking

55 / 4521

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Pennant Group Inc Highlights

StrengthsRisks

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Arizona, California, Colorado, Connecticut, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, Wyoming, Tennessee, Georgia and Alabama. Each of these businesses is operated by a separate, independent operating subsidiary. Its segments include home health and hospice services, and senior living services. Its home health and hospice services segment includes its home health, hospice and home care businesses. Its home health services provide care after surgery or when illness or health conditions require additional assistance. Its senior living services segment includes the operation of assisted living, independent living and memory care communities. Its independent living communities are designed for active individuals or couples.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 46.91% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 695.24M.

Fairly Valued

The company’s latest PE is 39.29, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 33.54M shares, decreasing 1.98% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 85.00 shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.89.

Analyst Rating

Based on 7 analysts

Strong Buy

Current Rating

35.833

Target Price

+23.91%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Pennant Group Inc is 8.24, ranking 28 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 229.04M, representing a year-over-year increase of 26.76%, while its net profit experienced a year-over-year increase of 2.00%.

Score

Industry at a Glance

Previous score

8.24

Change



Financials

5.58

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

9.19

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.84

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.60

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Pennant Group Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Pennant Group Inc is 5.96, ranking 64 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 39.29, which is 73.51% below the recent high of 68.17 and 36.82% above the recent low of 24.82.

Score

Industry at a Glance

Previous score

5.96

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 8/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Pennant Group Inc is 9.14, ranking 1 out of 75 in the Healthcare Providers & Services industry. The average price target is 35.50, with a high of 39.00 and a low of 30.00.

Score

Industry at a Glance

Previous score

9.14

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 7 analysts

Strong Buy

Current Rating

35.833

Target Price

+23.91%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Pennant Group Inc

PNTG

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Pennant Group Inc is 9.17, ranking 12 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 32.64 and the support level at 27.36, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.06

Change

0.11

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.173

Buy

RSI(14)

59.220

Neutral

STOCH(KDJ)(9,3,3)

75.756

Buy

ATR(14)

1.437

Low Volatility

CCI(14)

65.011

Neutral

Williams %R

30.142

Buy

TRIX(12,20)

-0.019

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

29.338

Buy

MA10

28.731

Buy

MA20

29.096

Buy

MA50

29.007

Buy

MA100

26.994

Buy

MA200

26.592

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Pennant Group Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 96.97%, representing a quarter-over-quarter increase of 1.85%. The largest institutional shareholder is The Vanguard, holding a total of 2.04M shares, representing 5.90% of shares outstanding, with 4.03% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Van Berkom & Associates Inc.

3.11M

+10.07%

BlackRock Institutional Trust Company, N.A.

2.29M

-0.60%

The Vanguard Group, Inc.

Star Investors

1.96M

-6.15%

8 knots Management LLC

1.74M

-34.35%

Paradigm Capital Management, Inc.

1.42M

+49.82%

Ophir Asset Management Pty Ltd

1.07M

+1.93%

Kent Lake PR LLC

865.00K

+85.98%

Geode Capital Management, L.L.C.

816.17K

-1.96%

Dimensional Fund Advisors, L.P.

805.99K

+8.16%

State Street Investment Management (US)

791.50K

+1.29%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Pennant Group Inc is 7.50, ranking 21 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.26. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.